发明名称 |
Treatment of subnormal bone mineral density |
摘要 |
A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE). |
申请公布号 |
US7612034(B2) |
申请公布日期 |
2009.11.03 |
申请号 |
US20040024557 |
申请日期 |
2004.12.28 |
申请人 |
GENELABS TECHNOLOGIES, INC. |
发明人 |
SCHWARTZ KENNETH E. |
分类号 |
A61K38/00;A61K45/00;A61K31/519;A61K31/568;A61K31/5685;A61K31/573;A61K31/663;A61K38/22;A61K38/23;A61P19/08;A61P19/10;A61P37/06;A61P43/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|